Skip to main content
Clinical Trials/NCT01384838
NCT01384838
Completed
Not Applicable

Randomized Trial of Exercise Training in Postmenopausal Patients With Hormone-receptor Positive Breast Cancer Undergoing Treatment With Aromatase Inhibitors

Arbeitsgemeinschaft medikamentoese Tumortherapie1 site in 1 country80 target enrollmentJune 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Physical Activity
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Enrollment
80
Locations
1
Primary Endpoint
Individual maximum power output in watt (Pmax) on a bicycle ergometer after 6 months of controlled or unobserved physical activity.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This randomized trial aims to assess if a well defined subgroup of breast cancer patients benefit from a controlled physical activity program.

All patients will be screened for their physical ability to complete the interventional exercise program. Only patients capable and willing to take part in this study and meeting all inclusion and exclusion criteria will be randomized.

All patients are to receive identical counseling for ideal nutritional, life-style and physical activity.

Patients randomized to Arm 2 will additionally undergo a controlled and observed program of physical activity for a period of 6 months. Thereafter the patients are expected to adhere to a comparable, unobserved exercise program at home.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
April 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent
  • Postmenopausal women with hormone receptor positive breast cancer (as defined by HR \>= ++ and/or PR \>= ++) who are treated with aromatase inhibitors
  • ECOG performance status \<= 2
  • all age groups

Exclusion Criteria

  • Pathologic ergometry
  • Uncontrolled diabetes mellitus
  • Uncontrolled hypertension
  • COPD \> II
  • Active opportunistic infection
  • NYHA heart failure III or IV

Outcomes

Primary Outcomes

Individual maximum power output in watt (Pmax) on a bicycle ergometer after 6 months of controlled or unobserved physical activity.

Time Frame: after 6 months

Secondary Outcomes

  • Determination of feasibility of achieving 12 MET/week (metabolic units) on an outpatient basis(after 6 and 12 months)
  • Evaluation of the influence of controlled/observed physical activity versus lifestyle counseling only on Fitness level, Quality of Life, rate of infections, weight, body mass index BMI, Body fat percentage(after 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials